Similar articles for PMID: 28244073

Year	Number of Results
1951	1
1993	1
1997	1
1999	3
2000	1
2002	2
2003	2
2005	1
2006	3
2007	5
2008	5
2009	8
2010	10
2011	6
2012	11
2013	12
2014	8
2015	12
2016	24
2017	45
2018	53
2019	61
2020	74
2021	66
2022	39
2023	27
2024	0

1

NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?

Ingram JR, Burton T. Ingram JR, et al. Br J Dermatol. 2017 Feb;176(2):281-282. doi: 10.1111/bjd.15255. Br J Dermatol. 2017. PMID: 28244073 No abstract available.

2

Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.

Harde V, Mrowietz U. Harde V, et al. J Dtsch Dermatol Ges. 2009 Feb;7(2):139-41. doi: 10.1111/j.1610-0387.2008.06918.x. J Dtsch Dermatol Ges. 2009. PMID: 19371236 English, German.

3

Management of patients with hidradenitis suppurativa.

Martorell A, Caballero A, González Lama Y, Jiménez-Gallo D, Lázaro Serrano M, Miranda J, Pascual JC, Salgado-Boquete L, Marín-Jiménez I. Martorell A, et al. Actas Dermosifiliogr. 2016 Sep;107 Suppl 2:32-42. doi: 10.1016/S0001-7310(17)30007-8. Actas Dermosifiliogr. 2016. PMID: 28081768 Free article. Review. English, Spanish.

4

Adalimumab for Treating Moderate-to-Severe Hidradenitis Suppurativa: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Tappenden P, Carroll C, Stevens JW, Rawdin A, Grimm S, Clowes M, Kaltenthaler E, Ingram JR, Collier F, Ghazavi M. Tappenden P, et al. Pharmacoeconomics. 2017 Aug;35(8):805-815. doi: 10.1007/s40273-017-0488-2. Pharmacoeconomics. 2017. PMID: 28176188 Free article. Review.

5

Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy.

Arenbergerova M, Gkalpakiotis S, Arenberger P. Arenbergerova M, et al. Int J Dermatol. 2010 Dec;49(12):1445-9. doi: 10.1111/j.1365-4632.2010.04638.x. Int J Dermatol. 2010. PMID: 21091684 Clinical Trial.

6

Concomitant psoriasis and hidradenitis suppurativa responsive to adalimumab therapy: A case series.

Yen CF, Huang YH, Chi CC. Yen CF, et al. Indian J Dermatol Venereol Leprol. 2021 Mar-Apr;87(2):223-226. doi: 10.4103/ijdvl.IJDVL_455_18. Indian J Dermatol Venereol Leprol. 2021. PMID: 31389375 Free article.

7

Adalimumab (Humira^®) for Hidradenitis Suppurativa.

Gupta AK, Cernea M, Abramovits W, Vincent KD. Gupta AK, et al. Skinmed. 2016 Aug 1;14(4):291-294. eCollection 2016. Skinmed. 2016. PMID: 27784520 No abstract available.

8

Association and management of Crohn's disease plus hidradenitis suppurativa.

dos Santos CH, Netto PO, Kawaguchi KY, Parreira Alves JA, de Alencar Souza VP, Reverdito S. dos Santos CH, et al. Inflamm Bowel Dis. 2012 Apr;18(4):E801-2. doi: 10.1002/ibd.21897. Epub 2011 Oct 12. Inflamm Bowel Dis. 2012. PMID: 21993924 No abstract available.

9

Hidradenitis suppurativa and immune dysregulation.

Jemec GB. Jemec GB. Br J Dermatol. 2012 Feb;166(2):237-8. doi: 10.1111/j.1365-2133.2012.10802.x. Br J Dermatol. 2012. PMID: 22268854 No abstract available.

10

[Hidradenitis suppurativa treated with infliximab].

Obadia DL, Daxbacher EL, Jeunon T, Gripp AC. Obadia DL, et al. An Bras Dermatol. 2009 Nov-Dec;84(6):695-7. doi: 10.1590/s0365-05962009000600022. An Bras Dermatol. 2009. PMID: 20191188 Portuguese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

394 results

Results by year